Yahoo Web Search

  1. Ad

    related to: Immunodeficiency

Search results

    • Moderna (NASDAQ:MRNA) PT Raised to $106.00

      ETF DAILY NEWS· 5 days ago

      Moderna (NASDAQ:MRNA – Free Report) had its price target increased by Canaccord Genuity Group from $91.00 to $106.00 in a report published on Friday, Benzinga reports. Canaccord Genuity Group ...